TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING NEBIVOLOL FOR THE TREATMENT OF DIABETIC WOUNDS
The present invention relates to a stable topical pharmaceutical composition of nebivolol for the treatment of diabetic wounds in a subject, wherein the time for complete wound closure (in days) after topical administration of the composition is less than or equal to that of the marketed product, be...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | PRASAD, LAKSHMI GUPTA, NEETA AKHTAR, SHAHNAZ SHINGATGERI, VYAS MADHAVRAO MAKWANA, ANIL KOCHHAR, RAVI BHELONDE, JAIPRAKASH JAYSINGRA BEDI, SIMRATA SHELAR, PANKAJ DA |
| description | The present invention relates to a stable topical pharmaceutical composition of nebivolol for the treatment of diabetic wounds in a subject, wherein the time for complete wound closure (in days) after topical administration of the composition is less than or equal to that of the marketed product, becaplermin gel.
La présente invention concerne une composition pharmaceutique topique stable de nébivolol pour le traitement de plaies diabétiques chez un sujet, le temps pour achever la fermeture de la plaie (en jours) après l'administration topique de la composition étant inférieur ou égal à celui du produit commercialisé, le gel bécaplermine. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2016108130A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2016108130A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2016108130A13</originalsourceid><addsrcrecordid>eNqNjMEKgkAQQL10iOofBjoHuwnRdV3HHNAd2R31FCKxnaIE-38K6QM6PR483jq5CjdkTQVNaXxtLLayqOW64UBC7MIingK5CzjMqOOKKyjYg5QI4tFIjU6AC8jJZPg9QM-ty8M2Wd3Hxxx3P26SfYFiy0OcXkOcp_EWn_E99HxU-qTVWafK6PS_6gP10jPh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING NEBIVOLOL FOR THE TREATMENT OF DIABETIC WOUNDS</title><source>esp@cenet</source><creator>PRASAD, LAKSHMI ; GUPTA, NEETA ; AKHTAR, SHAHNAZ ; SHINGATGERI, VYAS MADHAVRAO ; MAKWANA, ANIL ; KOCHHAR, RAVI ; BHELONDE, JAIPRAKASH JAYSINGRA ; BEDI, SIMRATA ; SHELAR, PANKAJ DA</creator><creatorcontrib>PRASAD, LAKSHMI ; GUPTA, NEETA ; AKHTAR, SHAHNAZ ; SHINGATGERI, VYAS MADHAVRAO ; MAKWANA, ANIL ; KOCHHAR, RAVI ; BHELONDE, JAIPRAKASH JAYSINGRA ; BEDI, SIMRATA ; SHELAR, PANKAJ DA</creatorcontrib><description>The present invention relates to a stable topical pharmaceutical composition of nebivolol for the treatment of diabetic wounds in a subject, wherein the time for complete wound closure (in days) after topical administration of the composition is less than or equal to that of the marketed product, becaplermin gel.
La présente invention concerne une composition pharmaceutique topique stable de nébivolol pour le traitement de plaies diabétiques chez un sujet, le temps pour achever la fermeture de la plaie (en jours) après l'administration topique de la composition étant inférieur ou égal à celui du produit commercialisé, le gel bécaplermine.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160707&DB=EPODOC&CC=WO&NR=2016108130A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160707&DB=EPODOC&CC=WO&NR=2016108130A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PRASAD, LAKSHMI</creatorcontrib><creatorcontrib>GUPTA, NEETA</creatorcontrib><creatorcontrib>AKHTAR, SHAHNAZ</creatorcontrib><creatorcontrib>SHINGATGERI, VYAS MADHAVRAO</creatorcontrib><creatorcontrib>MAKWANA, ANIL</creatorcontrib><creatorcontrib>KOCHHAR, RAVI</creatorcontrib><creatorcontrib>BHELONDE, JAIPRAKASH JAYSINGRA</creatorcontrib><creatorcontrib>BEDI, SIMRATA</creatorcontrib><creatorcontrib>SHELAR, PANKAJ DA</creatorcontrib><title>TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING NEBIVOLOL FOR THE TREATMENT OF DIABETIC WOUNDS</title><description>The present invention relates to a stable topical pharmaceutical composition of nebivolol for the treatment of diabetic wounds in a subject, wherein the time for complete wound closure (in days) after topical administration of the composition is less than or equal to that of the marketed product, becaplermin gel.
La présente invention concerne une composition pharmaceutique topique stable de nébivolol pour le traitement de plaies diabétiques chez un sujet, le temps pour achever la fermeture de la plaie (en jours) après l'administration topique de la composition étant inférieur ou égal à celui du produit commercialisé, le gel bécaplermine.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjMEKgkAQQL10iOofBjoHuwnRdV3HHNAd2R31FCKxnaIE-38K6QM6PR483jq5CjdkTQVNaXxtLLayqOW64UBC7MIingK5CzjMqOOKKyjYg5QI4tFIjU6AC8jJZPg9QM-ty8M2Wd3Hxxx3P26SfYFiy0OcXkOcp_EWn_E99HxU-qTVWafK6PS_6gP10jPh</recordid><startdate>20160707</startdate><enddate>20160707</enddate><creator>PRASAD, LAKSHMI</creator><creator>GUPTA, NEETA</creator><creator>AKHTAR, SHAHNAZ</creator><creator>SHINGATGERI, VYAS MADHAVRAO</creator><creator>MAKWANA, ANIL</creator><creator>KOCHHAR, RAVI</creator><creator>BHELONDE, JAIPRAKASH JAYSINGRA</creator><creator>BEDI, SIMRATA</creator><creator>SHELAR, PANKAJ DA</creator><scope>EVB</scope></search><sort><creationdate>20160707</creationdate><title>TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING NEBIVOLOL FOR THE TREATMENT OF DIABETIC WOUNDS</title><author>PRASAD, LAKSHMI ; GUPTA, NEETA ; AKHTAR, SHAHNAZ ; SHINGATGERI, VYAS MADHAVRAO ; MAKWANA, ANIL ; KOCHHAR, RAVI ; BHELONDE, JAIPRAKASH JAYSINGRA ; BEDI, SIMRATA ; SHELAR, PANKAJ DA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2016108130A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2016</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PRASAD, LAKSHMI</creatorcontrib><creatorcontrib>GUPTA, NEETA</creatorcontrib><creatorcontrib>AKHTAR, SHAHNAZ</creatorcontrib><creatorcontrib>SHINGATGERI, VYAS MADHAVRAO</creatorcontrib><creatorcontrib>MAKWANA, ANIL</creatorcontrib><creatorcontrib>KOCHHAR, RAVI</creatorcontrib><creatorcontrib>BHELONDE, JAIPRAKASH JAYSINGRA</creatorcontrib><creatorcontrib>BEDI, SIMRATA</creatorcontrib><creatorcontrib>SHELAR, PANKAJ DA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PRASAD, LAKSHMI</au><au>GUPTA, NEETA</au><au>AKHTAR, SHAHNAZ</au><au>SHINGATGERI, VYAS MADHAVRAO</au><au>MAKWANA, ANIL</au><au>KOCHHAR, RAVI</au><au>BHELONDE, JAIPRAKASH JAYSINGRA</au><au>BEDI, SIMRATA</au><au>SHELAR, PANKAJ DA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING NEBIVOLOL FOR THE TREATMENT OF DIABETIC WOUNDS</title><date>2016-07-07</date><risdate>2016</risdate><abstract>The present invention relates to a stable topical pharmaceutical composition of nebivolol for the treatment of diabetic wounds in a subject, wherein the time for complete wound closure (in days) after topical administration of the composition is less than or equal to that of the marketed product, becaplermin gel.
La présente invention concerne une composition pharmaceutique topique stable de nébivolol pour le traitement de plaies diabétiques chez un sujet, le temps pour achever la fermeture de la plaie (en jours) après l'administration topique de la composition étant inférieur ou égal à celui du produit commercialisé, le gel bécaplermine.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2016108130A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING NEBIVOLOL FOR THE TREATMENT OF DIABETIC WOUNDS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T07%3A03%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PRASAD,%20LAKSHMI&rft.date=2016-07-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2016108130A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |